iTeos Therapeutics, Inc.
ITOS
$7.77
$0.273.60%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.81M | -134.41M | -121.25M | -108.14M | -135.31M |
| Total Depreciation and Amortization | 1.26M | 1.24M | 1.14M | 1.07M | 980.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.05M | 16.35M | 20.87M | 19.20M | 18.35M |
| Change in Net Operating Assets | 12.96M | 18.65M | -18.20M | -26.11M | 6.37M |
| Cash from Operations | -99.55M | -98.18M | -117.44M | -113.98M | -109.60M |
| Capital Expenditure | -789.00K | -1.63M | -2.88M | -3.53M | -3.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.07M | -129.52M | -80.34M | 34.51M | 38.54M |
| Cash from Investing | -13.86M | -131.15M | -83.21M | 30.97M | 34.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 122.73M | 122.72M | 122.75M | 122.72M | 557.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -477.00K | -477.00K | -488.00K | -- | -- |
| Cash from Financing | 122.25M | 122.24M | 122.26M | 122.72M | 557.00K |
| Foreign Exchange rate Adjustments | 1.08M | -1.93M | -1.96M | -4.79M | -4.39M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.93M | -109.02M | -80.35M | 34.92M | -78.68M |